دورية أكاديمية
Effects of obstructive sleep apnea on non-alcoholic fatty liver disease in patients with obesity: a systematic review
| العنوان: | Effects of obstructive sleep apnea on non-alcoholic fatty liver disease in patients with obesity: a systematic review |
|---|---|
| المؤلفون: | Hany, Mohamed, Abouelnasr, Anwar Ashraf, Abdelkhalek, Mohamed Hesham, Ibrahim, Mohamed, Aboelsoud, Mostafa R., Hozien, Adel Ibrahim, Torensma, Bart |
| المصدر: | International Journal of Obesity ; volume 47, issue 12, page 1200-1213 ; ISSN 0307-0565 1476-5497 |
| بيانات النشر: | Springer Science and Business Media LLC |
| سنة النشر: | 2023 |
| مصطلحات موضوعية: | Nutrition and Dietetics, Endocrinology, Diabetes and Metabolism, Medicine (miscellaneous) |
| الوصف: | Introduction Obesity has been linked to non-alcoholic fatty liver disease (NAFLD), a widespread chronic liver ailment, as well as obstructive sleep apnea (OSA). The development of NAFLD is influenced by repeated intermittent hypoxia, a feature of OSA. Methods This systematic review (SR) investigated CENTRAL, PubMed, and EMBASE databases. The endpoint of this SR was to assess which OSA-related indicators could predict the presence of NAFLD and the effect of bariatric metabolic surgery (BMS) on improving OSA and NAFLD over time. Results Compared to previous SRs published in 2013, 14 new publications were added to our SR, alongside studies conducted prior to 2013. The SR ultimately included 28 studies (18 cross-sectional and 10 cohort trials). In the majority of studies, significant correlations were observed between OSA, OSA-related outcomes, and NAFLD. However, the apnea-hypopnea index (AHI) alone proved to be an inadequate predictor of NAFLD. Instead, respiratory and metabolic changes were found to alleviate oxidative stress induced by hypoxemia. Six studies involved patients who underwent BMS, with one evaluating patients before and after BMS, revealing associations between increased OSA and NAFLD improvement following BMS. Six months after surgery, 100% of patients in the mild-to-moderate OSA group were free from fatty liver, and an 89% reduction was observed in the severe OSA group. Conclusion For the first time, BMS has been tested in treating both OSA and NAFLD pre and postoperative with positive results. Further research, ideally with histological and functional data, is needed to confirm these findings. The SR identified 14 distinct liver outcome tests; however, high heterogeneity and incomplete data precluded a meta-analysis. It is imperative to pay greater attention to the influence of OSA-related factors and uniformity in liver outcomes testing concerning NAFLD. To accomplish this, study designs should be enhanced by incorporating more comprehensive pre- and postoperative evaluations, ... |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1038/s41366-023-01378-2 |
| الإتاحة: | https://doi.org/10.1038/s41366-023-01378-2Test https://www.nature.com/articles/s41366-023-01378-2.pdfTest https://www.nature.com/articles/s41366-023-01378-2Test |
| حقوق: | https://creativecommons.org/licenses/by/4.0Test ; https://creativecommons.org/licenses/by/4.0Test |
| رقم الانضمام: | edsbas.392D1516 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1038/s41366-023-01378-2 |
|---|